Cancer Care Michael Rauh 613-533-2818 michael.rauh@queensu.ca SEAMO, Kingston General Hospital, Queen's UniversityWith funds from the AHSC AFP Innovation Fund, we have successfully established the Queen’s Lab for Personalized Myeloid Cancer Pathology and Research (QMyPath – http://www.queensu.ca/rauhlab ). We have designed a high-throughput, next-generation DNA sequencing assay and have demonstrated...
Towards earlier detection and personalized diagnosis in Myelodysplastic Syndrome (MDS): a SEAMO-driven initiative of the Canadian MDS Consortium
M. Rauh
![](https://ifpoc.org/wp-content/uploads/2016/07/michael_rauh.jpg)